DIR Fee Relief and Defending Patient Access
In the community…
Report visiting a pharmacist in the past 12 months.
In policy…
Agree that change is needed in rules that result in below-cost or unpredictable reimbursement from payers to pharmacies.
In the community…
Say pharmacists are credible information sources on prescription drug savings.
In policy…
Support pharmacists using their expertise to build on 2018’s “gag-clause” prevention law and identify other ways to lower patients’ costs.
National poll of 1,995 registered voters, conducted January 4-6, 2019, by Morning Consult and commissioned by NACDS (margin of error +/- 2%).
In the community…
Report visiting a pharmacist in the past 12 months.
In policy…
Agree that change is needed in rules that result in below-cost or unpredictable reimbursement from payers to pharmacies.
In the community…
Say pharmacists are credible information sources on prescription drug savings.
In policy…
Support pharmacists using their expertise to build on 2018’s “gag-clause” prevention law and identify other ways to lower patients’ costs.
National poll of 1,995 registered voters, conducted January 4-6, 2019, by Morning Consult and commissioned by NACDS (margin of error +/- 2%).
DIR Fee White Paper Describes
“Lack of Clarity, Fairness and Transparency”
DIR Fees Growing to Over 6% of Medicare Part D Sales
RESOURCES
DIR Fee Relief: Reducing Costs, Improving Health
Reforming pharmacy DIR fees will save patients $7.1 to $9.2 billion over 10 years.
A review of 160 studies revealed that medication adherence significantly decreases as the medication cost to the patient increases.
Disease-specific cost of non-adherence is estimated up to $44,190 per person, and costs attributed to ʻall causesʼ non-adherence is estimated up to $52,341 per person.
If 25% of hypertension patients who were non-adherent became adherent, Medicare could save nearly $14 billion annually, averting over 100,000 emergency room visits and 7 million inpatient hospital days.